Wet Macular Degeneration

• CLINICAL_TRIALS trial_result · 2026-08-03
  Clinical Trial Results: A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) [Phase 3]

  Phase 3 clinical trial results evaluating the efficacy and safety of ONS-5010 in subjects with neovascular age-related macular degeneration.

• CLINICAL_TRIALS trial_result · 2026-07-17
  Clinical Trial Results: A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders [Phase 3]

  Phase 3 trial assessing the safety of ONS-5010 in subjects with visual impairment due to retinal disorders completed with results posted.

• CLINICAL_TRIALS trial_result · 2026-06-30
  Clinical Trial Results: A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) [Phase 3]

  Phase 3 trial results for ONS-5010 in neovascular age-related macular degeneration completed with posted results.

• CLINICAL_TRIALS trial_result · 2025-03-19
  Clinical Trial Update: A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) [Phase 3]

  Phase 3 trial evaluating the efficacy and safety of ONS-5010 in neovascular age-related macular degeneration has completed.

• CLINICAL_TRIALS trial_result · 2022-12-06
  Clinical Trial Update: Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration [Phase 3]

  Phase 3 trial evaluating aflibercept after ranibizumab in exudative age-related macular degeneration has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2021-03-15
  Clinical Trial Update: Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) [Phase 2]

  Phase 2 open-label study of intravitreal ICON-1 in choroidal neovascularization due to age-related macular degeneration has been terminated …

• CLINICAL_TRIALS trial_result · 2020-10-06
  Clinical Trial Update: Ziv-aflibercept Efficacy in Better Regulating AMD [Phase 2]

  Phase 2 trial update on ziv-aflibercept for wet macular degeneration shows efficacy signals in regulating disease.

• CLINICAL_TRIALS trial_result · 2020-08-13
  Clinical Trial Update: Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD [Phase 3]

  Phase 3 trial update reporting on safety and ECG data collection for brolucizumab 6 mg intravitreal treatment in wet age-related macular deg…

• CLINICAL_TRIALS trial_result · 2020-06-19
  Clinical Trial Update: Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration [Phase 2, Phase 3]

  A Phase 2/Phase 3 clinical trial evaluating dorzolamide-timolol in combination with anti-VEGF injections for neovascular/wet age-related mac…

• CLINICAL_TRIALS trial_result · 2019-12-03
  Clinical Trial Update: Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. [Phase 2]

  Phase 2 trial evaluating dorzolamide-timolol drops administered with injections for wet AMD, age-related macular degeneration, diabetic macu…

• CLINICAL_TRIALS trial_result · 2018-11-30
  Clinical Trial Update: Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy [Phase 4]

  Phase 4 trial comparing intravitreal ranibizumab with triamcinolone acetonide (TA) combination therapy versus ranibizumab alone for polypoid…